---
figid: PMC4434605__nihms685906f2
figtitle: Investigational cancer drugs targeting cell metabolism in clinical development
organisms:
- Escherichia coli
- Dickeya chrysanthemi
- Homo sapiens
- Silybum marianum
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4434605
filename: nihms685906f2.jpg
figlink: /pmc/articles/PMC4434605/figure/F2/
number: F2
caption: 'Multiple agents have shown the propensity to inhibit various steps of the
  glycolytic pathway. Silybin is an inhibitor of GLUT transporter proteins, londamine
  inhibits hexokinase, 2-deoxyglucose acts as a competitive inhibitor of glucose metabolism,
  AZD3965 is a MCT1 inhibitor, TLN-232 inhibits the PKM2 dimer, CPI-613 is a small
  molecular inhibitor of PDH and α-ketoglutarate dehydrogenase, and dichloroacetate
  (DCA) inhibits PDK.CoA: Coenzyme A; G6P: Glucose-6-phosphate; HK: Hexokinase; MCT:
  Monocarboxylate transporter; PDH: Pyruvate dehydrogenase complex; PDK: Pyruvate
  dehydrogenase kinase; PFK1: Phosphofructokinase 1; PKM: Pyrvate kinase isoenzyme;
  TCA: Tricarboxylic acid cycle.'
papertitle: Investigational cancer drugs targeting cell metabolism in clinical development.
reftext: Douglas W Sborov, et al. Expert Opin Investig Drugs. ;24(1):79-94.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9435554
figid_alias: PMC4434605__F2
figtype: Figure
redirect_from: /figures/PMC4434605__F2
ndex: ca89b751-def8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4434605__nihms685906f2.html
  '@type': Dataset
  description: 'Multiple agents have shown the propensity to inhibit various steps
    of the glycolytic pathway. Silybin is an inhibitor of GLUT transporter proteins,
    londamine inhibits hexokinase, 2-deoxyglucose acts as a competitive inhibitor
    of glucose metabolism, AZD3965 is a MCT1 inhibitor, TLN-232 inhibits the PKM2
    dimer, CPI-613 is a small molecular inhibitor of PDH and α-ketoglutarate dehydrogenase,
    and dichloroacetate (DCA) inhibits PDK.CoA: Coenzyme A; G6P: Glucose-6-phosphate;
    HK: Hexokinase; MCT: Monocarboxylate transporter; PDH: Pyruvate dehydrogenase
    complex; PDK: Pyruvate dehydrogenase kinase; PFK1: Phosphofructokinase 1; PKM:
    Pyrvate kinase isoenzyme; TCA: Tricarboxylic acid cycle.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC2A1
  - SLC2A3
  - PFKM
  - RASA1
  - RGS6
  - PDP1
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - PKM
  - PKLR
  - CMA1
  - SLC16A1
  - MCAT
  - MCTS1
  - SLC16A4
  - SLC16A3
  - PAEP
  - PREP
  - PTPN22
  - HLA-DQA2
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - Glut1
  - Glut3
  - G6P
  - Pfk
  - Gapdh2
  - CdGAPr
  - Gapdh1
  - RasGAP1
  - ArfGAP1
  - CycE
  - cyc
  - Pdh
  - Pdha
  - Pdf
  - Pdhb
  - Mct1
  - Pep
  - bgcn
  - smp-30
  - Pdk
  - Pdk1
  - AZD3965
  - Lonidamine
  - 2-deoxyglucose
  - Glucose
  - Pyruvate
  - Lactate
---
